Drug
Onivyde
Onivyde: highest development phase Phase 2, developed by Ipsen, Servier. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Ipsen, Servier
Trials
| Drug | Phase | Indication |
|---|---|---|
| Onivyde NCT03719924 | Phase 2 | Squamous Cell Carcinoma |
| Onivyde NCT04901702 | Phase 1/2 | Recurrent Solid Tumor |
Latest
No recent events.
Follow Onivyde on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.